University of Ljubljana

About: University of Ljubljana is a education organization based out in Ljubljana, Slovenia. It is known for research contribution in the topics: Population & Liquid crystal. The organization has 17210 authors who have published 47013 publications receiving 1082684 citations. The organization is also known as: Univerza v Ljubljani.

Production of actin‐specific ADP‐ribosyltransferase (binary toxin) by strains of Clostridium difficile

Abstract: In addition to the two large clostridial cytotoxins (TcdA and TcdB) certain strains of Clostridium difficile produce an actin-specific ADP-ribosyltransferase, or binary toxin. PCR reactions were developed to detect genes encoding the enzymatic (cdtA) and binding (cdtB) components of the binary toxin and 170 representative strains were tested to assess the prevalence of the toxin. Positive PCR results (n=59) were confirmed by immunoblotting and ADP-ribosyltransferase assay. PCR ribotype and toxinotype (restriction fragment length polymorphism analysis of genes for TcdA and TcdB) correlated with possession of binary toxin genes. All strains with cdtA and cdtB belonged to toxin-variable toxinotypes and five toxin-producing groups of strains have been described according to the presence or absence of TcdA, TcdB and binary toxin. Result indicate that ca. 6.4% of toxigenic isolates of C. difficile referred to the Anaerobe Reference Unit from UK hospitals have cdtA and cdtB genes.

Impact of the Carbon Coating Thickness on the Electrochemical Performance of LiFePO4 / C Composites

Abstract: Porous, well crystalline LiFePO 4 /C composites with different amounts of carbon have been prepared by a sol-gel technique. The thickness of carbon coatings (paintings) has been determined by high-resolution transmission electron microscopy. It is shown that carbon coating thickness can be controlled by the amount of carbon and it has an impact on the obtained reversible capacity. Furthermore, it is shown that atomic ratio of nonactive Fe(III) phase (presumably Fe 3 P) in as-synthesized LiFePO 4 /C composites depends on the amount of carbon in the composite. Using Mossbauer spectroscopy, we have confirmed that the nonactive Fe(III) remains nearly unchanged in the composite during cycling. The lowest amount of carbon in LiFePO 4 /C composites obtained from citrate anion as a gelling agent was 3.2 wt % and this particular amount corresponds to the carbon coating thickness of about 1-2 nm. The reversible capacity obtained from the above-mentioned composite delivers close to 80% of the theoretical capacity at room temperature with a current density of 170 mA/g (C/1 rate).

Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

Abstract: Allergic rhinitis (AR) and asthma represent global health problems for all age groups. Asthma and rhinitis frequently coexist in the same subjects. Allergic Rhinitis and its Impact on Asthma (ARIA) was initiated during a World Health Organization workshop in 1999 (published in 2001). ARIA has reclassified AR as mild/moderate-severe and intermittent/persistent. This classification closely reflects patients' needs and underlines the close relationship between rhinitis and asthma. Patients, clinicians, and other health care professionals are confronted with various treatment choices for the management of AR. This contributes to considerable variation in clinical practice, and worldwide, patients, clinicians, and other health care professionals are faced with uncertainty about the relative merits and downsides of the various treatment options. In its 2010 Revision, ARIA developed clinical practice guidelines for the management of AR and asthma comorbidities based on the Grading of Recommendation, Assessment, Development and Evaluation (GRADE) system. ARIA is disseminated and implemented in more than 50 countries of the world. Ten years after the publication of the ARIA World Health Organization workshop report, it is important to make a summary of its achievements and identify the still unmet clinical, research, and implementation needs to strengthen the 2011 European Union Priority on allergy and asthma in children.